{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:33:32Z","timestamp":1793658812331,"version":"4.5.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:00:00Z","timestamp":1542758400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11926-018-0794-5","type":"journal-article","created":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:34:47Z","timestamp":1542760487000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Pharmacological Treatment of Pain in Osteoarthritis: A Descriptive Review"],"prefix":"10.1007","volume":"20","author":[{"given":"Muhammad Hassan","family":"Majeed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Ali Amir","family":"Sherazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Bacon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahid H.","family":"Bajwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,21]]},"reference":[{"key":"794_CR1","doi-asserted-by":"crossref","unstructured":"Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med [Internet]. 2000;133:635\u201346. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11033593 .","DOI":"10.7326\/0003-4819-133-8-200010170-00016"},{"key":"794_CR2","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/art.20051","volume":"50","author":"DT Felson","year":"2004","unstructured":"Felson DT, Neogi T. Osteoarthritis: is it a disease of cartilage or of bone? Arthritis Rheum. 2004;50:341\u20134.","journal-title":"Arthritis Rheum"},{"key":"794_CR3","unstructured":"Man GS, Mologhianu G. Osteoarthritis pathogenesis\u2014a complex process that involves the entire joint. J Med Life [Internet]. Carol Davila - University Press; 2014;7:37\u201341. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24653755 ."},{"key":"794_CR4","doi-asserted-by":"crossref","unstructured":"Sokolove J, Lepus CM. Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations. Ther Adv Musculoskelet Dis [Internet]. 2013;5:77\u201394. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23641259 .","DOI":"10.1177\/1759720X12467868"},{"key":"794_CR5","doi-asserted-by":"crossref","unstructured":"Felson DT, Zhang Y, Hannan MT, Naimark A, Weissman BN, Aliabadi P, et al. The incidence and natural history of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum [Internet]. 1995;38:1500\u20135. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7575700 .","DOI":"10.1002\/art.1780381017"},{"key":"794_CR6","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","volume":"388","author":"C Allen","year":"2016","unstructured":"GBD 2015 Disease and Injury Incidence and Prevalence Collaborators T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet (Lond, Engl). 2016;388:1545\u2013602.","journal-title":"Lancet (Lond, Engl)"},{"key":"794_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/art.23176","volume":"58","author":"RC Lawrence","year":"2008","unstructured":"Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008;58:26\u201335.","journal-title":"Arthritis Rheum"},{"key":"794_CR8","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/acr.22721","volume":"68","author":"MG Cisternas","year":"2016","unstructured":"Cisternas MG, Murphy L, Sacks JJ, Solomon DH, Pasta DJ, Helmick CG. Alternative methods for defining osteoarthritis and the impact on estimating prevalence in a US population-based survey. Arthritis Care Res (Hoboken). 2016;68:574\u201380.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"794_CR9","unstructured":"Torio CM, Moore BJ. National inpatient hospital costs: the most expensive conditions by payer, 2013: statistical brief #204. Healthc. Cost Util. Proj. Stat. Briefs. Agency for Healthcare Research and Quality (US); 2006."},{"key":"794_CR10","doi-asserted-by":"publisher","first-page":"iv43","DOI":"10.1093\/rheumatology\/kex419","volume":"57","author":"K Fu","year":"2018","unstructured":"\u2022 Fu K, Robbins SR, McDougall JJ. Osteoarthritis: the genesis of pain. Rheumatology. 2018;57:iv43\u201350. This study provides updated information about the mechanism, types, and mediators of pain in OA.","journal-title":"Rheumatology"},{"key":"794_CR11","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1002\/j.1532-2149.2014.499.x","volume":"18","author":"E Lluch","year":"2014","unstructured":"Lluch E, Torres R, Nijs J, Van Oosterwijck J. Evidence for central sensitization in patients with osteoarthritis pain: a systematic literature review. Eur J Pain. 2014;18:1367\u201375.","journal-title":"Eur J Pain"},{"key":"794_CR12","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/jnc.12093","volume":"124","author":"L McKelvey","year":"2013","unstructured":"McKelvey L, Shorten GD, O\u2019Keeffe GW. Nerve growth factor-mediated regulation of pain signalling and proposed new intervention strategies in clinical pain management. J Neurochem. 2013;124:276\u201389.","journal-title":"J Neurochem"},{"key":"794_CR13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s11914-015-0291-y","volume":"13","author":"E Cohen","year":"2015","unstructured":"\u2022 Cohen E, Lee YC. A mechanism-based approach to the management of osteoarthritis pain. Curr Osteoporos Rep. 2015;13:399\u2013406. This study provides a clear understanding of the development of pain in OA as well as its management based on the mechanism of the origin of the pain.","journal-title":"Curr Osteoporos Rep"},{"key":"794_CR14","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1002\/art.34466","volume":"64","author":"T Graven-Nielsen","year":"2012","unstructured":"Graven-Nielsen T, Wodehouse T, Langford RM, Arendt-Nielsen L, Kidd BL. Normalization of widespread hyperesthesia and facilitated spatial summation of deep-tissue pain in knee osteoarthritis patients after knee replacement. Arthritis Rheum. 2012;64:2907\u201316.","journal-title":"Arthritis Rheum"},{"key":"794_CR15","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1002\/art.22460","volume":"56","author":"B Kulkarni","year":"2007","unstructured":"Kulkarni B, Bentley DE, Elliott R, Julyan PJ, Boger E, Watson A, et al. Arthritic pain is processed in brain areas concerned with emotions and fear. Arthritis Rheum. 2007;56:1345\u201354.","journal-title":"Arthritis Rheum"},{"key":"794_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4103\/0975-7406.106561","volume":"5","author":"D Bhatia","year":"2013","unstructured":"Bhatia D, Bejarano T, Novo M. Current interventions in the management of knee osteoarthritis. J Pharm Bioallied Sci. 2013;5:30\u20138.","journal-title":"J Pharm Bioallied Sci"},{"key":"794_CR17","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/annrheumdis-2017-212662","volume":"77","author":"R Geenen","year":"2018","unstructured":"\u2022 Geenen R, Overman CL, Christensen R, \u00c5senl\u00f6f P, Capela S, Huisinga KL, et al. EULAR recommendations for the health professional\u2019s approach to pain management in inflammatory arthritis and osteoarthritis. Ann Rheum Dis. 2018;77:797\u2013807. EULAR narrates evidence and expert opinion in order to provide recommendations concerning the management of pain in OA.","journal-title":"Ann Rheum Dis"},{"key":"794_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/sj.ijo.0803715","volume":"32","author":"A Anandacoomarasamy","year":"2008","unstructured":"Anandacoomarasamy A, Caterson I, Sambrook P, Fransen M, March L. The impact of obesity on the musculoskeletal system. Int J Obes. 2008;32:211\u201322.","journal-title":"Int J Obes"},{"key":"794_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jsams.2010.08.002","volume":"14","author":"KL Bennell","year":"2011","unstructured":"Bennell KL, Hinman RS. A review of the clinical evidence for exercise in osteoarthritis of the hip and knee. J Sci Med Sport. 2011;14:4\u20139.","journal-title":"J Sci Med Sport"},{"key":"794_CR20","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1001\/jama.2013.277669","volume":"310","author":"SP Messier","year":"2013","unstructured":"Messier SP, Mihalko SL, Legault C, Miller GD, Nicklas BJ, DeVita P, et al. Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis. JAMA. 2013;310:1263\u201373.","journal-title":"JAMA"},{"key":"794_CR21","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/obr.12173","volume":"15","author":"H Bliddal","year":"2014","unstructured":"Bliddal H, Leeds AR, Christensen R. Osteoarthritis, obesity and weight loss: evidence, hypotheses and horizons\u2014a scoping review. Obes Rev. 2014;15:578\u201386.","journal-title":"Obes Rev"},{"key":"794_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ajp.2017.11.025","volume":"32","author":"MH Majeed","year":"2018","unstructured":"Majeed MH, Ali AA, Sudak DM. Mindfulness-based interventions for chronic pain: evidence and applications. Asian J Psychiatr. 2018;32:79\u201383.","journal-title":"Asian J Psychiatr"},{"key":"794_CR23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/PRA.0000000000000262","volume":"23","author":"MH Majeed","year":"2017","unstructured":"Majeed MH, Sudak DM. Cognitive behavioral therapy for chronic pain-one therapeutic approach for the opioid epidemic. J Psychiatr Pract. 2017;23:409\u201314.","journal-title":"J Psychiatr Pract"},{"key":"794_CR24","doi-asserted-by":"publisher","unstructured":"Majeed MH, Ali AA, Sudak DM. Psychotherapeutic interventions for chronic pain: evidence, rationale, and advantages. Int J Psychiatry Med. 2018. https:\/\/doi.org\/10.1177\/009121741879144 .","DOI":"10.1177\/009121741879144"},{"key":"794_CR25","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1136\/bmj.38273.626655.63","volume":"329","author":"JM Bjordal","year":"2004","unstructured":"Bjordal JM, Ljunggren AE, Klovning A, Sl\u00f8rdal L. Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials. BMJ. 2004;329:1317.","journal-title":"BMJ"},{"key":"794_CR26","first-page":"CD007400","volume-title":"Cochrane database syst rev","author":"S Derry","year":"2012","unstructured":"Derry S, Moore RA, Rabbie R. Topical NSAIDs for chronic musculoskeletal pain in adults. In: Derry S, editor. Cochrane database syst rev. Chichester: Wiley; 2012. p. CD007400."},{"key":"794_CR27","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S0140-6736(17)31744-0","volume":"390","author":"BR Costa da","year":"2017","unstructured":"da Costa BR, Reichenbach S, Keller N, Nartey L, Wandel S, J\u00fcni P, et al. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet (Lond, Engl). 2017;390:e21\u201333.","journal-title":"Lancet (Lond, Engl)"},{"key":"794_CR28","doi-asserted-by":"crossref","unstructured":"Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, et al. OARSI recommendations for the management of hip and knee osteoarthritis. Osteoarthr Cartil [Internet]. 2010;18:476\u201399. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20170770 .","DOI":"10.1016\/j.joca.2010.01.013"},{"key":"794_CR29","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1093\/ageing\/afs072","volume":"41","author":"S Abou-Raya","year":"2012","unstructured":"Abou-Raya S, Abou-Raya A, Helmii M. Duloxetine for the management of pain in older adults with knee osteoarthritis: randomised placebo-controlled trial. Age Ageing. 2012;41:646\u201352.","journal-title":"Age Ageing"},{"key":"794_CR30","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1185\/03007995.2011.633502","volume":"27","author":"EP Frakes","year":"2011","unstructured":"Frakes EP, Risser RC, Ball TD, Hochberg MC, Wohlreich MM. Duloxetine added to oral nonsteroidal anti-inflammatory drugs for treatment of knee pain due to osteoarthritis: results of a randomized, double-blind, placebo-controlled trial. Curr Med Res Opin. 2011;27:2361\u201372.","journal-title":"Curr Med Res Opin"},{"key":"794_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3810\/pgm.2012.01.2521","volume":"124","author":"L Citrome","year":"2012","unstructured":"Citrome L, Weiss\u2013Citrome A. A systematic review of duloxetine for osteoarthritic pain: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed? Postgrad Med. 2012;124:83\u201393.","journal-title":"Postgrad Med"},{"key":"794_CR32","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1136\/bmj.38042.506748.EE","volume":"328","author":"L Mason","year":"2004","unstructured":"Mason L, Moore RA, Derry S, Edwards JE, McQuay HJ. Systematic review of topical capsaicin for the treatment of chronic pain. BMJ. 2004;328:991.","journal-title":"BMJ"},{"key":"794_CR33","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/newbio231232a0","volume":"231","author":"JR Vane","year":"1971","unstructured":"Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971;231:232\u20135.","journal-title":"Nat New Biol"},{"key":"794_CR34","doi-asserted-by":"crossref","unstructured":"Cashman JN. The mechanisms of action of NSAIDs in analgesia. Drugs [Internet]. 1996;52 Suppl 5:13\u201323. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8922554 .","DOI":"10.2165\/00003495-199600525-00004"},{"key":"794_CR35","unstructured":"Chou R, McDonagh MS, Nakamoto E, Griffin J. Analgesics for osteoarthritis. Analg. Osteoarthr. An Updat. 2006 Comp. Eff. Rev. Agency for Healthcare Research and Quality (US); 2011."},{"key":"794_CR36","doi-asserted-by":"crossref","unstructured":"Kienzler J-L, Gold M, Nollevaux F. Systemic bioavailability of topical diclofenac sodium gel 1% versus Oral diclofenac sodium in healthy volunteers. J Clin Pharmacol [Internet]. 2010;50:50\u201361. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19841157 .","DOI":"10.1177\/0091270009336234"},{"issue":"Suppl 3","key":"794_CR37","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/ar4175","volume":"15","author":"C Sostres","year":"2013","unstructured":"Sostres C, Gargallo CJ, Lanas A. Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage. Arthritis Res Ther. 2013;15(Suppl 3):S3.","journal-title":"Arthritis Res Ther"},{"key":"794_CR38","doi-asserted-by":"publisher","first-page":"385","DOI":"10.5001\/omj.2011.101","volume":"26","author":"A Al-Saeed","year":"2011","unstructured":"Al-Saeed A. Gastrointestinal and cardiovascular risk of nonsteroidal anti-inflammatory drugs. Oman Med J. 2011;26:385\u201391.","journal-title":"Oman Med J"},{"key":"794_CR39","doi-asserted-by":"crossref","unstructured":"Krijthe BP, Heeringa J, Hofman A, Franco OH, Stricker BH. Non-steroidal anti-inflammatory drugs and the risk of atrial fibrillation: a population-based follow-up study. BMJ Open [Internet]. 2014 [cited 2018 Sep 12];4:e004059. Available from: http:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2013-004059 .","DOI":"10.1136\/bmjopen-2013-004059"},{"key":"794_CR40","unstructured":"J\u00f3\u017awiak-Bebenista M, Nowak JZ. Paracetamol: mechanism of action, applications and safety concern. Acta Pol Pharm [Internet]. 2014;71:11\u201323. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24779190 ."},{"key":"794_CR41","doi-asserted-by":"crossref","unstructured":"Towheed T, Maxwell L, Judd M, Catton M, Hochberg MC, Wells GA. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev. 2006;CD004257.","DOI":"10.1002\/14651858.CD004257.pub2"},{"key":"794_CR42","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1136\/ard.2003.018531","volume":"63","author":"W Zhang","year":"2004","unstructured":"Zhang W, Jones A, Doherty M. Does paracetamol (acetaminophen) reduce the pain of osteoarthritis?: a meta-analysis of randomised controlled trials. Ann Rheum Dis. 2004;63:901\u20137.","journal-title":"Ann Rheum Dis"},{"key":"794_CR43","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1159\/000374090","volume":"33","author":"H Jaeschke","year":"2015","unstructured":"Jaeschke H. Acetaminophen: dose-dependent drug hepatotoxicity and acute liver failure in patients. Dig Dis. 2015;33:464\u201371.","journal-title":"Dig Dis"},{"key":"794_CR44","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.reuma.2016.07.008","volume":"14","author":"V Guedes","year":"2018","unstructured":"Guedes V, Castro JP, Brito I. Topical capsaicin for pain in osteoarthritis: a literature review. Reumatol Clin. 2018;14:40\u20135.","journal-title":"Reumatol Clin"},{"key":"794_CR45","doi-asserted-by":"crossref","unstructured":"Dowell D, Haegerich TM, Chou R. CDC Guideline for prescribing opioids for chronic pain\u2014United States, 2016. JAMA [Internet]. 2016 [cited 2017 Jan 17];315:1624. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26977696 .","DOI":"10.1001\/jama.2016.1464"},{"issue":"Suppl 1","key":"794_CR46","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1111\/pme.12914","volume":"16","author":"P Yi","year":"2015","unstructured":"Yi P, Pryzbylkowski P. Opioid induced hyperalgesia. Pain Med. 2015;16(Suppl 1):S32\u20136.","journal-title":"Pain Med"},{"key":"794_CR47","doi-asserted-by":"crossref","unstructured":"Brat GA, Agniel D, Beam A, Yorkgitis B, Bicket M, Homer M, et al. Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study. BMJ [Internet]. 2018 [cited 2018 Sep 11];j5790. Available from: http:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.j5790 .","DOI":"10.1136\/bmj.j5790"},{"key":"794_CR48","first-page":"CD005614","volume-title":"Cochrane database syst rev","author":"JA Singh","year":"2015","unstructured":"Singh JA, Noorbaloochi S, MacDonald R, Maxwell LJ. Chondroitin for osteoarthritis. In: Singh JA, editor. Cochrane database syst rev. Chichester: Wiley; 2015. p. CD005614."},{"key":"794_CR49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/annrheumdis-2014-206792","volume":"75","author":"MC Hochberg","year":"2016","unstructured":"Hochberg MC, Martel-Pelletier J, Monfort J, M\u00f6ller I, Castillo JR, Arden N, et al. Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Ann Rheum Dis. 2016;75:37\u201344.","journal-title":"Ann Rheum Dis"},{"key":"794_CR50","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1136\/bmj.38039.573970.7C","volume":"328","author":"B Arroll","year":"2004","unstructured":"Arroll B, Goodyear-Smith F. Corticosteroid injections for osteoarthritis of the knee: meta-analysis. BMJ. 2004;328:869.","journal-title":"BMJ"},{"key":"794_CR51","doi-asserted-by":"publisher","first-page":"e6599","DOI":"10.5867\/medwave.2016.6599","volume":"16","author":"J Fa\u00fandez","year":"2016","unstructured":"Fa\u00fandez J, Cotoras P, Irarr\u00e1zaval S. Are intraarticular steroids effective for knee osteoarthritis? Medwave. 2016;16:e6599.","journal-title":"Medwave"},{"key":"794_CR52","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1177\/0363546512471299","volume":"41","author":"S Patel","year":"2013","unstructured":"Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med. 2013;41:356\u201364.","journal-title":"Am J Sports Med"},{"key":"794_CR53","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1177\/0363546516665809","volume":"45","author":"BJ Cole","year":"2017","unstructured":"Cole BJ, Karas V, Hussey K, Merkow DB, Pilz K, Fortier LA. Hyaluronic acid versus platelet-rich plasma: a prospective, double-blind randomized controlled trial comparing clinical outcomes and effects on intra-articular biology for the treatment of knee osteoarthritis. Am J Sports Med. 2017;45:339\u201346.","journal-title":"Am J Sports Med"},{"key":"794_CR54","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/j.joca.2016.07.017","volume":"24","author":"MA Karsdal","year":"2016","unstructured":"Karsdal MA, Michaelis M, Ladel C, Siebuhr AS, Bihlet AR, Andersen JR, et al. Disease-modifying treatments for osteoarthritis (DMOADs) of the knee and hip: lessons learned from failures and opportunities for the future. Osteoarthr Cartil. 2016;24:2013\u201321.","journal-title":"Osteoarthr Cartil"},{"key":"794_CR55","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1001\/jama.283.11.1469","volume":"283","author":"TE McAlindon","year":"2000","unstructured":"McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA. 2000;283:1469\u201375.","journal-title":"JAMA"},{"key":"794_CR56","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1136\/annrheumdis-2013-203954","volume":"74","author":"M Fransen","year":"2015","unstructured":"Fransen M, Agaliotis M, Nairn L, Votrubec M, Bridgett L, Su S, et al. Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens. Ann Rheum Dis. 2015;74:851\u20138.","journal-title":"Ann Rheum Dis"},{"key":"794_CR57","doi-asserted-by":"publisher","first-page":"JC27","DOI":"10.7326\/ACPJC-2017-167-6-027","volume":"167","author":"LE Hart","year":"2017","unstructured":"Hart LE. In knee OA, intraarticular triamcinolone increased cartilage loss and did not differ from saline for knee pain. Ann Intern Med. 2017;167:JC27.","journal-title":"Ann Intern Med"},{"key":"794_CR58","doi-asserted-by":"publisher","first-page":"538","DOI":"10.2106\/00004623-200403000-00012","volume":"86\u2013A","author":"C-T Wang","year":"2004","unstructured":"Wang C-T, Lin J, Chang C-J, Lin Y-T, Hou S-M. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am. 2004;86\u2013A:538\u201345.","journal-title":"J Bone Joint Surg Am"},{"key":"794_CR59","doi-asserted-by":"publisher","first-page":"180","DOI":"10.7326\/0003-4819-157-3-201208070-00473","volume":"157","author":"AWS Rutjes","year":"2012","unstructured":"Rutjes AWS, J\u00fcni P, da Costa BR, Trelle S, N\u00fcesch E, Reichenbach S. Viscosupplementation for osteoarthritis of the knee. Ann Intern Med. 2012;157:180\u201391.","journal-title":"Ann Intern Med"},{"key":"794_CR60","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1093\/rheumatology\/kem234","volume":"46","author":"E Anitua","year":"2007","unstructured":"Anitua E, S\u00e1nchez M, Nurden AT, Zalduendo MM, de la Fuente M, Azofra J, et al. Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients. Rheumatology (Oxford). 2007;46:1769\u201372.","journal-title":"Rheumatology (Oxford)"},{"key":"794_CR61","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/j.joca.2014.10.003","volume":"23","author":"TJ Schnitzer","year":"2015","unstructured":"Schnitzer TJ, Marks JA. A systematic review of the efficacy and general safety of antibodies to NGF in the treatment of OA of the hip or knee. Osteoarthr Cartil. 2015;23:S8\u201317.","journal-title":"Osteoarthr Cartil"},{"key":"794_CR62","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1136\/annrheumdis-2013-204905","volume":"74","author":"TJ Schnitzer","year":"2015","unstructured":"Schnitzer TJ, Ekman EF, Spierings ELH, Greenberg HS, Smith MD, Brown MT, et al. Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain. Ann Rheum Dis. 2015;74:1202\u201311.","journal-title":"Ann Rheum Dis"},{"key":"794_CR63","doi-asserted-by":"publisher","first-page":"e0157105","DOI":"10.1371\/journal.pone.0157105","volume":"11","author":"S-L Kan","year":"2016","unstructured":"Kan S-L, Li Y, Ning G-Z, Yuan Z-F, Chen L-X, Bi M-C, et al. Tanezumab for patients with osteoarthritis of the knee: a meta-analysis. PLoS One. 2016;11:e0157105.","journal-title":"PLoS One"},{"key":"794_CR64","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.pain.2014.03.018","volume":"155","author":"PJ Tiseo","year":"2014","unstructured":"Tiseo PJ, Kivitz AJ, Ervin JE, Ren H, Mellis SJ. Fasinumab (REGN475), an antibody against nerve growth factor for the treatment of pain: results from a double-blind, placebo-controlled exploratory study in osteoarthritis of the knee. Pain. 2014;155:1245\u201352.","journal-title":"Pain"},{"key":"794_CR65","doi-asserted-by":"publisher","first-page":"R199","DOI":"10.1186\/ar4037","volume":"14","author":"AD Cook","year":"2012","unstructured":"Cook AD, Pobjoy J, Steidl S, D\u00fcrr M, Braine EL, Turner AL, et al. Granulocyte-macrophage colony-stimulating factor is a key mediator in experimental osteoarthritis pain and disease development. Arthritis Res Ther. 2012;14:R199.","journal-title":"Arthritis Res Ther"},{"key":"794_CR66","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nrd4612","volume":"14","author":"A Mullard","year":"2015","unstructured":"Mullard A. Drug developers reboot anti-NGF pain programmes. Nat Rev Drug Discov. 2015;14:297\u20138.","journal-title":"Nat Rev Drug Discov"},{"key":"794_CR67","doi-asserted-by":"publisher","first-page":"pnw262","DOI":"10.1093\/pm\/pnw262","volume":"18","author":"J Chen","year":"2016","unstructured":"Chen J, Li J, Li R, Wang H, Yang J, Xu J, et al. Efficacy and safety of tanezumab on osteoarthritis knee and hip pains: a meta-analysis of randomized controlled trials. Pain Med. 2016;18:pnw262.","journal-title":"Pain Med"},{"key":"794_CR68","doi-asserted-by":"publisher","first-page":"iv99","DOI":"10.1093\/rheumatology\/kex522","volume":"57","author":"RE Miller","year":"2018","unstructured":"Miller RE, Block JA, Malfait A-M. What is new in pain modification in osteoarthritis? Rheumatology. 2018;57:iv99\u2013iv107.","journal-title":"Rheumatology"},{"key":"794_CR69","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1517\/14728222.2016.1162295","volume":"20","author":"EC Emery","year":"2016","unstructured":"Emery EC, Luiz AP, Wood JN. Na v 1.7 and other voltage-gated sodium channels as drug targets for pain relief. Expert Opin Ther Targets. 2016;20:975\u201383.","journal-title":"Expert Opin Ther Targets"},{"key":"794_CR70","doi-asserted-by":"publisher","first-page":"eaar3483","DOI":"10.1126\/scitranslmed.aar3483","volume":"10","author":"H Ding","year":"2018","unstructured":"Ding H, Kiguchi N, Yasuda D, Daga PR, Polgar WE, Lu JJ, et al. A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates. Sci Transl Med. 2018;10:eaar3483.","journal-title":"Sci Transl Med"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-018-0794-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-018-0794-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-018-0794-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:24:01Z","timestamp":1775276641000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-018-0794-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,21]]},"references-count":70,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["794"],"URL":"https:\/\/doi.org\/10.1007\/s11926-018-0794-5","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,21]]},"assertion":[{"value":"21 November 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Prior Abstract Publication\/Presentation"}}],"article-number":"88"}}